LOAd713 treatment decreased multiple profibrotic factors including LAP-TGF-β1, type I collagen, FGF5, HGF, and TWEAK. LOAd713 increased immune cell infiltration, inhibited tumor growth, and prolonged survival in syngeneic mouse models of melanoma. Here, TGFB1 is linked to melanoma.